title: LRRK2 as a therapeutic target in Parkinson's disease.
authors.forename: E K
authors.initials: EK
authors.lastname: Tan
authors.forename: A H
authors.initials: AH
authors.lastname: Schapira
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D009154:Mutation; D010300:Parkinson Disease / Q000188:drug therapy* / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*
chemical_list: D000978:Antiparkinson Agents; D004791:Enzyme Inhibitors; C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases